Thomas Wiggans, CEO & COB, Director at Dermira, holds 50.00K shares in Jasper Therapeutics (Ticker: JSPR), holds 0.00 shares in Pardes Biosciences (Ticker: PRDS), holds 0.00 shares in Forma Therapeutics Holdings (Ticker: FMTX). Most recently, Thomas Wiggans Bought ― shares of Jasper Therapeutics on Nov 30, 2023 for an estimated value of 6.40K.
Thomas Wiggans latest transaction was an Informative Buy of $6.40K.
What was Thomas Wiggans's most profitable transaction?
Thomas Wiggans’s most profitable transaction was an Informative Buy of JSPR stock on November 30, 2023. The return on the trade was 258.50%.
What is Thomas Wiggans's role in Dermira?
Thomas Wiggans's role in Dermira is CEO & COB, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.